This Breakthrough In Biotech Has Enormous Investment Potential – Forbes

Posted: Published on February 12th, 2017

This post was added by Dr. Richardson


Forbes
This Breakthrough In Biotech Has Enormous Investment Potential
Forbes
Asterias Biotherapeutics (AST) continues to generate excitement and buzz around its stem cell treatment for catastrophic spinal cord injury (SCI). I wrote about this historic event back in September. That's when the company first released results about ...

Visit link:
This Breakthrough In Biotech Has Enormous Investment Potential - Forbes

Related Posts
This entry was posted in Spinal Cord Injury Treatment. Bookmark the permalink.

Comments are closed.